Name

CAFTH

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for CAFTH

Name

Alternate Names

5-Fluorouracil
5-Fluracil
Adrucil
Efudex
Fluoroplex
Fluracil
Fluril
Oracil
Ro 2-9757
WR-69596

Abbreviations

5-FU
5FU
FU

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

019893
19893

Primary Site

Breast- adjuvant setting and advanced disease
colorectal- adjuvant setting and advanced disease
GI malignancies: anal, esophageal, gastric and pancreatic
Head and Neck cancer
Hepatoma
Ovarian cancer
Skin-Basal cell carcinoma (topical application)

Histology

None

Remarks

Fluorinated pyrimidine; antimetabolite. FDA approved uses on basal cell carcinoma, breast cancer, colorectal cancer, gastric cancer, and pancreatic cancer.

Note: Efudex cream be prescribed to treat AIN III. Code this as chemotherapy.

Coding

This drug should be coded

Name

Alternate Names

Androfluorene
Android-F
Anrosterolo
Fluo-testin
Fluoximesterone
Flusteron
Flutestos
Halodrin
Halotestin
Neo-Ormonal
Ora-Testryl#
Oralsterone
Oratestin
Testoral
Ultandren

Abbreviations

FLU
FXM
HAL

Category

Hormones and hormonal mechanisms

Subcategory

Androgen

NSC Number

012165
12165

Primary Site

Breast cancer

Histology

None

Remarks

A synthetic androgenic anabolic steroid used in the treatment of male hypogonadism and in the palliative therapy of inoperable female breast cancer in selected patients, administered orally.

Coding

This drug should be coded

Name

Alternate Names

Alpha-Tamoxifen
Apo-Tamox
Dom-Tamoxifen
Gen-Tamoxifen
ICI-46474
Nolvadex
Nolvadex-D
Novo-Tamoxifen
PMS-Tamoxifen
Tamofen
Tamone
Tamoplex
Tamoxifen
Tamoxifen Citrate
Soltamox

Abbreviations

TAM
TMX

Category

Hormones and hormonal mechanisms

Subcategory

Nonsteroidal antiestrogen

NSC Number

180973

Primary Site

Breast

Histology

None

Remarks

A nonsteroidal antiestrogenic agent with combined partial-estrogen-agonist activity. FDA approved uses on breast cancer and risk reduction for women with high risk of developing breast cancer.

Literature shows that Tamoxifen is being prescribed for recurrent/relapsed ovarian cancer.

Coding

This drug should be coded

Name

Alternate Names

14-hydroxy-daunomycin
Adri-blastina (Italy)
Adriamycin
Adriamycin-TM
Caelyx
FT-106
Hydroxydaunomycin
Myocet
Pegylated Liposomal Doxorubicin Hcl
Rubex
S-DOX
Stealth(R) Liposomal Doxorubicin

Abbreviations

ADM
ADR
ADRI

Category

Chemotherapy

Subcategory

Antitumor antibiotic

NSC Number

123127

Primary Site

Bladder
breast
liver
multiple myeloma
ovarian
pancreatic
prostate cancer

Histology

None

Remarks

Phase II liver, pancreatic, Phase III MM, prostate Doxorubicin hydrochloride encapsulated in liposomes formulated with methoxypolyethylene glycol (MPEG). FDA approved use on bladder cancer, breast cancer, gastric cancer, leukemia, small cell lung cancer, lymphoma, neuroblastoma, ovarian cancer, sarcoma, thyroid cancer, Wilm's tumor. ALZA Corp, NeoPharm, Pharmacia, Schering-Plough, Sequus. Antitumor antibiotic

Coding

This drug should be coded

Name

Alternate Names

Asta B 518
B-518
Clafen Claphene
Cyclophosphamid
Cyclophosphan
Cyclophosphane
Cytophosphan
Cytoxan
Endoxan
Endoxana
Enduxan
Genoxal
Neosar
Procytox
Sendoxan
Tymtram
WR-138719

Abbreviations

CP
CPM
CTX
CTY
CYC
Cyclo
CYT
CYTOX
CYTX

Category

Chemotherapy

Subcategory

Alkylating agent

NSC Number

026271
26271

Primary Site

Breast
leukemia
lymphoma
multiple myeloma
neuroblastoma
ovarian cancer
retinoblastoma
soft tissue sarcoma
Wilm's tumor

Histology

None

Remarks

An effective antineoplastic agent and is used for a variety of cancers. FDA approved uses on breast cancer, ovarian carcinoma, leukemia, lymphomas, multiple myeloma, neuroblastma, retinoblastoma, soft tissue sarcoma, Wilm's tumor. Alkylating agent

Coding

This drug should be coded
Glossary